Professional Documents
Culture Documents
Russian Journal of Electrochemistry
Russian Journal of Electrochemistry
Keywords: Cyclic voltammetry (CV), αglucosidase, medicinal plant extracts, inhibition activity, paranitro
phenylαDglucopyranoside (PNPG)
DOI: 10.1134/S1023193514120027
1
2 MOHIUDDIN et al.
ParanitrophenolαDglucopyranoside + H2O
AG enzyme 2.4. Preparation of Medicinal Plant Extracts
αDelucopyranose+ Paranitrophenol.
Tebengau (Ehretia laevis), Cemumar (Micromelum
Scheme. Enzymatic reaction of PNPG. pubescens), and Kedondong (Spondias dulcis) plant
leaves were collected from the Agrotechnology
PNPG is an electroactive substance because of the Research Station in Sungai Chuchuh, Perlis, Malay
presence a nitrophenyl Oglycoside group and release sia. The plant leaves were airdried and then crushed
paranitrophenol (pNP) upon hydrolysis in the pres into a powder. Aqueous extracts of the plant leaves
ence of AG enzyme. The released pNP is measured were prepared through an infusion method [27].
by the CV method. In the presence of a medicinal Essentially, 0.5 g of each type of leaf powder was dis
plant extract as an inhibitor, the liberated pNP will be solved in 100 ml of boiling (distilled) water, and the
reduced. Thus, the difference of the released pNP mixtures were allowed to infuse for 15 min without
defines as the antidiabetic potential of a medicinal additional heating. All of the samples were filtered
plant. through Whatman filter paper to obtain the extracts.
HO
O Antidiaoetic
αglucosidase potential
OH αDglucopyranose + pnianitrophenol
HO O NO2 a1
Herbal extracts
OH αDglucopyranose + pnianitrophenol a2
αglucosidase
Fig. 1. Principle of the measurement of the antidiabetic potential through the CV method.
2.5. Preparation of Acarbose Sample 2.8. Measurement Method of the Antidiabetic Potential
of Medicinal Plants
Acarbose is a commercial antidiabetic drug used
to treat type 2 diabetes mellitus. Acarbose slows the The antidiabetic potential measurement of medic
digestion of carbohydrates in the body and thus helps inal plants is based on the inhibition of AG enzyme
to control the blood sugar levels. Ten tablets were activity in conversion of PNPG into pNP according
weighed and ground into a homogeneous fine powder to the Fig. 1.
in a mortar, and the average weight of each tablet was The produced pNP will exhibit oxidation or
calculated. Then, a 1 mg/mL acarbose solution was reduction peak (а1) using the CV method. In the
prepared by dissolving the appropriate amount of presence of the medicinal plant extract, the peak
powdered acarbose in 50 mL of distilled water. would decrease (а2) inversely with the concentra
tion of the medicinal plant extract. Thus, the differ
ence between these two oxidation or reduction
2.6. Cyclic Voltammetric Measurement Method peaks define as the antidiabetic potential of the
medicinal plants.
The PNPG sample solution was prepared in 0.1 M
phosphate buffer of pH 6.5 with 0.1 M KCl as the sup
porting electrolyte. The AG enzyme solution 3. RESULTS AND DISCUSSION
(1.79 unit/mL) was prepared in 0.1 M phosphate 3.1. Cyclic Voltammetric (CV) Behaviour of PNPG
buffer at pH 6.5 and used for the enzymatic hydrolysis at MWCNTs Paste Electrode
of the PNPG solution. The plant extracts were used to
inhibit the enzymatic hydrolysis of the PNPG solution The voltammetric response of PNPG at
in order to measure the antidiabetic potential of the MWCNTs paste electrode was studied at the scan rate
medicinal plants. 50 mV/s with 0.1 M KCl solution using CV method.
PNPG is a synthetic electroactive chemical com
The cyclic voltammetric measurements were con pound due to presence of the nitrophenyl Oglyco
ducted using the fabricated MWCNTs paste electrode sides group. The effect of scan rate at MWCNTs paste
in a stirred PNPG sample solution for a given period of electrode for PNPG was observed using CV method.
time. The stirring was then stopped for 15 s to allow the The cyclic voltammograms of PNPG at various scan
solution to settle, and the cyclic voltammograms were rates (10 to 60 mV/s) are depicted in the Fig. 2a and
recorded at potential range between –0.6 to +0.6 V. The it shows that the oxidation and reduction peak cur
enzymatic hydrolysis reaction was performed at room rents increase linearly with the increasing of scan rate
temperature. The deposition potential (Edep) and time from 10 to 60 mV/s. The peak currents increase lin
(tdep) were set to –0.8 V and 20 s for each of the mea early to the square root of the scan rate for reversible
surements to obtain maximum peak current. electron transfer. The result from the plotting of ip
versus v1/2 in the Fig. 2b showed that the anodic and
cathodic peak currents varied linearly with the square
2.7. Colorimetric Measurement Method root of scan rate, suggesting that the redox reaction of
The colorimetric measurements were performed PNPG follows a diffusion controlled mechanism
using a Lambda25 UVVIS spectrometer (PerkinElmer, [29]. In addition, the peak potential shifted with the
USA). The 0.1 M PNPG and enzyme solution were increasing of the scan rate. The larger separation in
mixed through stirring to allow enzymatic hydrolysis the peak potentials and the shift of the peak potential
reaction indicating by the formation of yellowish pNP. with the scan rate indicate the quasireversible nature
After a certain period of time, 0.1 M sodium carbonate of the process [30].
solution was added to stop the enzymatic reaction and PNPG is hydrolysed by AG enzyme into para
pNP was measured at 400 nm [28]. nitrophenol and αDglucopyranose, as depicted in
(a) (b)
Oxidation peak
10 10
8
Oxidation peak
6 6
60 mV/s
Current, µA
4 40 mV/s R 2 = 0.987
40 mV/s
2 30 mV/s 2
20 mV/s
0 10 mV/s
–2 –2 R 2 = 0.995
–4
Reduction peak Reduction peak
–6 –6
–0.4 –0.2 0 0.2 0.4 0.6 0 2 4 6 8 10
Potential, V Square root of scan rate
Fig. 2. (a) Cyclic voltammograms of PNPG in 0.1 M phosphate buffer of pH 6.5 at the MWCNTs paste electrode with different
scan rates (10, 20, 30, 40, 50, and 60 mV/s), (b) the corresponding plot of the oxidation and reduction peak current as a function
of the square root of the different scan rates.
(a)
40 PNPG
(b)
PNPG + Enzyme Growing released pNP
20
reduction peak current
20
Current, µA
16
Current, µA
0 Growing released 12
pNP reduction
peak current
8
–20 Decreasing attached pNP
Decreasing attached pNP 1 reduction peak current
reduction peak
–40 0
–0.6 –0.2 0.2 0.6 5 15 25 35
Potential, V Time, min
Fig. 3. (a) Cyclic voltammograms of PNPG before (red) and after the addition of enzyme (black), (b) Decrease in the PNPG
peak current (attached pNP peak) and increase in the reduction peak current of released pNP as a function of time.
the scheme. The decrease in the amount of PNPG 3.2. Measurement of the Antidiabetic Potential
and the release of pNP yielded by the above reaction of Medicinal Plants and a Commercial Drug, Acarbose
can be followed on the MWCNTs paste electrode In the presence of an inhibitor, such as the bioactive
through the cyclic voltammetric method, as shown in compounds in medicinal plants extracts, both the deteri
the Fig. 3a. The corresponding plots of the decrease oration of PNPG reduction peak and the increasing rate
in the PNPG peak (attached pNP peak) and the of the pNP are slower. The results in Figs. 4a and 4b show
growth of the released pNP peak as a function of that the reduction peak current of the released pNP from
time are indicated in the Fig. 3b. Thus, either the enzymatic reaction inhibited by the Tebengau plant
increase value of pNP as well as the deterioration of extract is lower than that obtained with Acarbose, Cemu
PNPG reduction peak currents obtained in this sys mar and Kedondong plant extracts. This suggests that the
tem can be used to measure the AG enzyme activity. inhibition of AG by Tebengau is higher than that obtained
However, the value of the oxidation peaks cannot be by Acarbose, Cemumar and Kedondong.
used as it appears to be constant due to the overlap The percentage of inhibition by medicinal plant
ping of PNPG (attached pNP) and released pNP extracts and acarbose was calculated according to the
peaks at around 0.16 V. Eq. (1) [31] which is shown in Fig. 4c.
60 (c)
% of inhibition
40
20
(a)
0
10
ar ar
be e
em g
au
on ol
Te bos
C don
Ac um
ed tr
ng
4.50 (b)
K on
C
Control
3.50
Current, µA
Kedondong
PNPG Cemumar
Current, µA
0 Tebengau
Acarbose 2.50
Cemumar Acarbose
Kedondong
Tebengau
Control
1.50
–10
0.50
Fig. 4. (a) Cyclic voltammograms of PNPG in the presence of the enzyme and the medicinal plant extracts, (b) Reduction peak
current of released pNP over time in the presence of Tebengau (Ehretia laevis), Cemumar (Micromelum pubescens), Kedondong
(Spondias dulcis), and acarbose, (c) % of inhibition of Tebengau, Cemumar Kedondong and acarbose.
The inhibition kinetics of AG enzyme by the in the presence of the Tebengau plant extract is shown
medicinal extracts was analyzed using the Lin in Fig. 6. There was a good correlation (R2 = 0.987)
eweaver–Burk equation which is shown as Eq. (2): between these two methods, which indicates the high
accuracy of the presented CV method. The correlation
1 = ⎛
Km ⎞ ⎛ 1 ⎞ 1 curves for acarbose (R2 = 0.977), Cemumar (R2 =
+ . (2)
V0 ⎝ V max⎠ ⎝ [ S ]⎠ V max 0.966) and Kedondong (R2 = 0.971) are not shown.
Fig. 5 shows the Lineweaver–Burk plot of the
effect of different concentrations of Tebengau plant 20 μL (2 mg/mL)
extracts on the activity of the AG enzyme at different 35 Tebengau herbal extracts
concentrations of PNPG. The results are shown in
table. It is noticeable that the apparent Km value
25 20 μL (1 mg/mL)
increases with an increase in concentration of the
1/V, µA/min
Km and Vmax values at different concentrations of the Teben grams. There was no other peak response appeared
gau plant extracts and same inhibition was observed as without interfer
ences which is shown in Fig. 7. Thus indicating the
Concentration excellent selectivity of the MWCNTs paste electrode
Vmax value,
of Tebengau plant Km value, mM to measure the antidiabetic potential of medicinal
µA/min
extract, µL plants as well as commercial antidiabetic drugs.
4. CONCLUSIONS
Tebengau
14 PNPG has been widely used as a colourproducing
pNitrophenol (µg/mL)
10
Current, µA
0 Acarbose
Control
–5
–10
–0.4 0 0.4
Potential, V
ity and the inhibition efficiency of the medicinal plant 6. Patil, A., Nirmal, S., Pattan, S., Tambe, V., and
extracts. Tare, M., Phytopharmacoogyl., 2012, vol. 2, p. 46.
The fabricated PNPGbased MWCNT paste elec 7. Han, C.J., Hussin, A.H., and Ismail, S., Trop. Biomed.,
2008, vol. 25, p. 9.
trode exhibited good sensitivity for the measurement
of the inhibition of the AG enzyme reaction by medic 8. Kim, J., Hyun, T.K., and Kim, M., Food Chem., 2011,
inal plant extracts. The MWCNT paste electrode also vol. 124, p. 1647.
showed good repeatability and reproducibility. The 9. Vinholes, J., Grosso, C, Andrade, P.B., Gil.Izquierdo, A.,
electrode is useful for determining the antidiabetic Valentao, P., Pinho, P.G., and Ferreres, F., Food Chem.,
2011, vol. 129, p. 454.
potential of medicinal plant extracts. The electrode
construction was simple and utilises no unstable or 10. Nain, P., Saini, V., Sharma, S., and Nain, J., J. Ethnop
harmacol., 2012, vol. 142, p. 65.
toxic materials. Thus, this electrode can be regarded as
green based on economic and environment concerns. 11. Patel, D.K., Prasad,S.K., Kumar, R., and Hemalatha, S.,
The extension of this work for the development of a Asian Pac. J. Trop. Biomed., 2012, p. 320.
reagentless and disposable biosensor for the practical 12. He, H., Li, X., Chen, X., Ye, X., Huang, J., Jin, Y.,
and easy measurements of the antidiabetic potential of Li, P., Deng, Y., Jin, Q., Shi, Q., and Shu, H., J. Ethno
pharmacol., 2011, vol. 137, p. 1135.
medicinal plants is reported separately.
13. Kumar, V.G., Gokavarapu, S.D., Rajeswari, A.,
Dhas, T.S., Karthick, V., Kapadia, Z., Shrestha, T.,
ACKNOWLEDGMENTS Barathy, I.A., Roy, A., and Sinha, S., Colloids Surf. B,
2011, vol. 87, p. 159.
The researchers would like to thank the University 14. Goldberg, R.B., Rosenson, R.S., HernandezTriana, E.,
Malaysia Perlis (UniMAP) for their financial support Misir, S., and Jones, M.R., J. Clin. Lipidol., 2012,
and the grant provided for this research work. vol. 6, p. 318.
15. Shivanna, N., Naika, M., Khanum, F., and Kaul, V.K.,
J. Diabetes Complications., 2013, vol. 27, p. 103.
REFERENCES
16. Kumar, S., Vasudeva, N., and Sharma, S., Cardiovasc.
1. World Health Organization, 2011. Diabeto., 2012, vol. 95, p. 1.
2. Buse, J.B., Henry, R.R., Han, J., Kim, D.D., Fine 17. Elries, M.A.N., Mohamed, G.G., and Attia, A.K.,
man, M.S., and Baron, A.D., Diabetes Care, 2004, Yakugaku zasshi, 2008, vol. 128, p. 171.
vol. 27, p. 2628. 18. Timur, S. and Anik, U., Anal. Chim. Acta, 2007,
3. Madsbad, S., Eu. J. Intern. Med., 2012, vol. 23, p. 132. vol. 598, p. 143.
1 4. Phan, M.A.T., Wang, J., Tang. J., Lee, Y.Z., and 19. Silva, F.D.A.D.S., Lopes, C.B., Kubota, L.T.,
Ng, K., LWT—Food Scien. Technol., 2013, vol. 53, Lima, P.R., and Goulart, M.O.F., Sens. Actuators B,
p. 492. 2012, vol. 168, p. 289.
5. Yu, Z., Yin, Y., Zhao, W., Yu, Y., Liu, B., Liu, J., and 20. Deng, P., Fei, J., and Feng, Y., Sens. Actuators B, 2010,
Chen, F., Food Chem., 2011, vol. 129, p. 1376. vol. 148, p. 214.
21. Jeykumari, D.R.S., Ramaprabhu, S., and Narayanan, S.S., 27. Giao, M.S., Leitao, I., Pereira, A., Borges, A.B.,
Carbon, 2007, vol. 45, p. 1340. Guedes, C.J., Fernandes, J.C., Belo, L., SantosSilva, A.,
22. Sanghavi, B.J., Sitaula, S., Griep, M.H., Kama, S.P., Hogg, T.A., Pintado, M.E., and Malcata, F.X., Food
Ali, M.F., and Swami, N.S., Anal. Chem., 2013, vol. 85, Control, 2010, vol. 21, p. 633.
p. 8158. 28. Gomez, J.M., Romero, M.D., and Fernandez, T.M.,
23. Sanghavi, B.J. and Srivastava, A.K., Analyst, 2013, Catal. Lett., 2005, vol. 101, p. 3.
vol. 138, p. 1395. 29. Gadhari, N.S., Sanghavi, B.J., and Srivastava, A.K.,
24. Sanghavi, B.J. and Srivastava, A.K., Electrochim. Acta, Anal. Chim. Acta, 2011, vol. 703, p. 31.
2010, vol. 55, p. 8638. 30. Gao, H., Duan, Y., Xi, M., and Sun, W., Microchim.
25. Sanghavi, B.J., Mobin, S.M., Mathur, P., Lahiri, G.K., Acta, 2011, vol., 172, p. 57.
and Srivastava, A.K., Biosens. Bioelectron., 2013, 31. Du, D., Wang, M., Cai, J., Qin, Y., and Zhang, A.,
vol. 39, p. 124. Sens. Actuators B, 2010, vol. 143, p. 524.
26. Svancara, I., Vytras, K., Kalcher, K., Walcarius, A., and 32. Jao, C., Huang, S., and Hsu, K., BioMedicine, 2012,
Wang, J., Electroanal., 2009, vol. 21, p. 7. vol. 2, p. 130.
SPELL: 1. ok